Please visit the COVID-19 response page for resources and advice on managing through the crisis today and beyond.
To accommodate the speed at which the industry is evolving, leading organizations are embracing digital transformation. Yet, there are challenges in integrating digital into your overall business strategy, including cultivating a company culture focused on stakeholder experiences.
Cognizant is redefining the way life sciences companies do digital. That's why all 30 of the top 30 global pharmaceutical companies, nine of the top 10 biotech companies and 12 of the top 15 medical device companies work with us.
Learn from Dr. Anthony S. Fauci, Arianna Huffington, Cognizant’s head of Life Sciences Srinivas Shankar and others from the Wall Street Journal’s recent Tech Health event held during “this extraordinary time in the history of global health.”LEARN MORE
Discover how advanced technologies and significant changes can help us mitigate the impact of global health crises like COVID-19.READ MORE
Based on our discussions with life sciences leaders, we predict four long-term effects from the pandemic on supply chains.READ MORE
Virtual healthcare, data science and digital interoperability can help the healthcare ecosystem remain effective in a chaotic pandemic.READ MORE
As healthcare expenditures increase, life sciences firms are recognizing how value-based contracts can reduce costs to healthcare payers and lower out-of-pocket costs to patients.READ THE STUDY
The key to improve customer experience across life sciences is transforming the entire enterprise through a tightly integrated approach across front- and back-end processes.READ THE REPORT
Cognizant named top provider of life sciences digital services for second straight year. The global report analyzes the changing dynamics of the life sciences services landscape.READ THE PRESS RELEASE
Cognizant strengthens Industry 4.0 offering with new end-to-end smart factory capabilities. The acquisition extends Cognizant’s capabilities for designing, implementing and managing end-to-end operational and information technology systems for connected biopharmaceutical and medical device manufacturers.READ THE PRESS RELEASE
Services and solutions that help industry leaders improve product development and manufacturing processes across key operational functions.
Cognizant offers a broad array of consulting services and solutions for life sciences, global pharmaceutical and biotech companies.
The COVID-19 pandemic has changed the clinical trial landscape. Cognizant® Shared Investigator Platform (SIP) offers a way forward amid the challenges of the current environment. The platform provides clinical researchers a better trial experience. Cognizant SIP is a cloud-based solution, built and developed by a consortium of leading biopharmaceutical companies that came together to share information and standardize workflows.
Cognizant offers solutions specific to the challenges of life sciences companies. Browse the pages below to learn more.
Life Sciences Products & Platforms:
Stay on top of what's happening across Cognizant.
Come out and meet us at these upcoming events.